Skip to main content

Table 1 Clinical characteristics of the study population

From: Risk of malignancy in kidney transplant recipients: a nationwide population-based cohort study

Clinical characteristic

KT group (n = 12,634)

Control group (n = 12,634)

P

Age (years)

  

 < 0.001

Under 20

0 (0.0)

6 (0.1)

 

20–34

790 (6.3)

5818 (46.1)

 

35–49

5145 (40.7)

3931 (31.1)

 

50–64

6040 (47.8)

1812 (14.3)

 

65 or over

659 (5.2)

1067 (8.4)

 

Sex

  

 < 0.001

Male

8310 (65.8)

6073 (48.1)

 

Female

4324 (34.2)

6561 (51.9)

 

Insurance type

  

 < 0.001

Social health insurance

10,781 (85.3)

12,134 (96.0)

 

Medical aid

1852 (14.7)

495 (3.9)

 

Veterans

1 (0.0)

5 (0.1)

 

Person with comorbidities

5816 (46.0)

803 (6.4)

 < 0.001

Type of comorbidities

Diabetes mellitus

4009 (31.7)

313 (2.5)

 < 0.001

Ischemic heart disease

1869 (14.8)

202 (1.6)

 < 0.001

Heart failure

1241 (9.8)

65 (0.5)

 < 0.001

Liver cirrhosis

1083 (8.6)

341 (2.7)

 < 0.001

Chronic obstructive pulmonary disease

234 (1.9)

55 (0.4)

 < 0.001

  1. KT kidney transplantation
  2. Data are presented as n (%)